中药熏蒸配合推拿治疗腰腿痛的疗效观察及护理

目的 观察中药熏蒸配合推拿治疗腰腿痛的疗效,总结其护理要点.方法 回顾性分析我科2009年3月～2011年3月采用中药熏蒸配合推拿治疗的84例腰腿痛患者的临床资料、治疗方法、护理措施和疗效.结果 治愈25例,好转56例,无效3例,有效率达96.4%.疗程最长35天,最短3天,平均12.7天.结论 中药熏蒸配合推拿治疗腰腿痛疗效显著.     

手法配合机械牵引、中药热敷治疗腰腿痛560例临床观察

目的:减轻腰腿痛病人症状.方法:采用手法、牵引、中药热敷等综合治疗.结果:临床观察疗效较为理想.     

腰腿痛的中医外治及辨证施护

总结了1010例腰腿痛患者的中医外治法及辨证护理,采取的中医传统外治方法有推拿、针灸、牵引、拔罐、中药热敷、药物离子导入等.辨证施护包括:生活起居的护理、情志调护、饮食指导、药膳治疗、康复指导等.认为中医治疗腰腿痛有很好的疗效,而辨证施护是中医护理的精髓,可有效地预防腰腿痛的发生、降低腰腿痛的发生率,减轻长期疾病给患者带来的痛苦,提高生活质量.     

中药离子导入治疗颈肩腰腿痛症的效果观察

目的 探讨中药离子导入治疗颈肩腰腿痛症的疗效.方法 100例痛症患者分为为2组,各50例,治疗组使用中药离子治疗与护理,对照组遵医嘱采用常规药物治疗与护理,观察2组的止痛效果.结果 治疗组在治疗后比对照组疼痛症状缓解(p<0.05).结论 中药离子导入治疗颈肩腰腿痛症效果满意,方法简便、经济,值得推广.     

臭氧治疗腰椎间盘突出症的疗效分析

腰椎间盘突出症是临床常见病、多发病,是引起腰腿痛的主要原因.目前治疗椎间盘突出症的方法很多,大多数患者通过理疗(锻炼、推拿、按摩治疗等)能够缓解.如果椎间盘脱出(髓核突出纤维环)则必须用创伤的方法来解除患者痛苦.传统开放式手术需经后路椎板摘除髓核,手术创伤大,部份病例遗留神经根粘连、硬膜纤维化等并发症,导致腰腿痛不能缓解或晚期下腰椎不稳定[1].随着现代医学的发展,微创手术作为一种新的治疗方法逐渐得到广大患者的认可.与此同时,医务工作者也认为微创手术具有风险小,无痛苦,起效迅速,疗效高,无过敏反应及其他明显并发症的优点,便于临床推广.     

综合疗法治疗小儿脑性瘫痪

目的:观察推拿等综合疗法治疗小儿脑性瘫痪的临床治疗效果.方法:以点穴、推拿、运动疗法等综合疗法对32例患儿进行治疗.结果:治疗1个月时患儿的智力、姿势、运动、肌张力等各指标均有明显改善,1月显效率为80%,2月显效率达85%,总有效率达85%以上.结论:本治疗方法能有效改善脑瘫患儿的临床症状,近期疗效确切,不失为一种有效的治疗方法.     

针推服药综合疗法治疗腰间盘突出症疗效观察

腰间盘突出症是骨伤科临床常见病多发病,据统计在门诊腰腿痛患者中有16%属于本病.现临床上多主张采用非手术治疗,得笔者自2001年来采用针刺加推拿治疗腰间盘突出症,获得满意疗效,现总结报告如下.     

曲美他嗪治疗糖尿病合并冠心病120例临床分析

目的:探讨曲美他嗪治疗糖尿病合并冠心病的临床疗效.方法:选取糖尿病伴冠心病患者240例,随机分成观察组和对照组,对照组患者采用常规冠心病药物治疗,观察组患者在常规治疗基础上加用曲美他嗪进行治疗,经过一个疗程的治疗后,分析两组患者的治疗效果.结果:曲美他嗪组疗效较常规治疗组疗效好,差异显著,有统计学意义.结论:曲美他嗪的疗效机制较适合糖尿病合并冠心病患者的治疗,即能有效改善心肌缺血的状况,同时对糖尿病本身也有改善作用,值得临床推广应用.     

中药熏蒸治疗风寒湿痹证的临床疗效观察

目的 观察中药熏蒸治疗风寒湿痹证的临床疗效.方法 将232例风寒湿痹证患者随机分治疗组137例和对照组95例,对照组采用常规针药结合治疗,治疗组在此基础上加用中药熏蒸治疗,比较2组患者的症状体征积分、血沉(ESR)、C-反应蛋白(CRP)的改善情况及临床疗效.结果 治疗组在改善症状体征积分和降低ESR、CRP方面均优于对照组(p<0.05或p<0.01);治疗组的疗效以对风痹、寒痹为主,其总有效率89.78%高于对照组80.00%(P<0.05).结论 中药熏蒸治疗风寒湿痹证能明显提高临床疗效,值得与常规疗法配合推广应用.     

电针配合推拿治疗神经根型颈椎病50例临床疗效观察

目的:观察电针配合推拿治疗神经根型颈椎病临床疗效.方法:运用电针加推拿治疗神经根型颈椎病25例并与单纯推拿治疗神经根型颈椎病25例对照比较疗效.结果:本次临床观察证实,经治疗后,两组病人临床疗效及疼痛程度均有较好的改善,自身前后对照均有显著性意义;两组间疼痛程度改善比较有显著差异(P<0.05).结论:电针推拿组疼痛程度改善优于推拿组.     

Behavior therapy and sex therapy

Behavior therapy is characterized by the way in which clinical data are collected, analyzed, and used in the treatment program-specifically, the application of the methods of experimental and social psychology. A case history of the behavioral treatment of a sexual problem is presented to illustrate this process. Many people have assumed that the "new sex therapy" is behavior therapy because of its focus on the here and now and similarities in particular treatment maneuvers. However, the author notes that sex therapy is behavior therapy only to the extent that it deals comprehensively with environmental, interpersonal, and organismic factors that operate to maintain the sexual problem.     

Pain therapy

NEW OPIOID ANALGESICS: Progress in pain reliet has recently been achieved with the introduction of new opioid analgesics such as tramadol and the pediatric preparation of codeine phosphate as well as powerful long-release opioids which can be administered per os, or percutaneously for transdermal fentanyl. CO-ANALGESICS: Other drugs, mainly antidepressants and anti-convulsants, can be usefully combined with analgesics. New serotonin uptake inhibitors and anticonvulsants (gabapentin and lamotrigin) have the advantage of better tolerance. None of these drugs has marketing approval in France for their pain relieving effects. The same is true for clonidine and neostigmine which, after spinal infusion, potentialize opioids and for ketamine which can relieve neuropathy pain by dissociative anesthesia. NEW ANTI-MIGRAINE DRUGS: New drugs have been developed for specific types of pain such as migraine. The new "triptans" are tolerated better than sumatriptan and is reimbursed by the national social security. REFRACTORY NEUROPATHY PAIN: Indications for electrical stimulation techniques conducted in a neurosurgery unit have been identified. Stimulators may be implanted in spinal or supra-spinal localizations. REGULATORY ASPECTS: New legislation has reorganized health care for pain relief in France. The new texts take into consideration personnel training, the health care network and progress in therapeutics.     

Nutritional therapy

This article describes nutritional therapy for hemorrhagic gastro-intestinal diseases. The aim of this therapy is to protect and to accelerate cure of hemorrhagic lesion with rapid recovery of general condition. The accurate judgement for fluid therapy and contents, volume and timing of dietetic therapy is very difficult. However, it should always be considered, that excellent nutritional therapy influences prognosis of hemorrhagic digestive diseases to a great degree for its medication.     

Nutritional therapy

Osteoporosis is one of the life style related diseases. Therefore, from the viewpoint of prevention, daily diet and nutrient intake are important. An adequate intake of calcium together with nutrient balance plays an essential role in maintaining and promoting health and preventing osteoporosis. Moreover, prior to nutritional therapy, it is essential to understand the current nutritional status and dietary habits of the individual.     

Methotrexate therapy

An association of schistosomiasis and endomyocardial fibrosis or cardiomyopathy has been suggested. Clinical, stool, abdominal ultrasound, electrocardiogram, and Doppler echocardiogram examinations were performed on 226 patients from an area endemic for schistosomiasis. The diagnosis of schistosomiasis was made in 152 patients (69%) but clinical, electrocardiographic, or Doppler echocardiographic evidence of a schistosome cardiomyopathy or endomyocardial fibrosis could not be detected in any patient.